A Few Steps Ahead to Select ACE2 in Pediatric COVID-19 Treatment: A Review of Literature | ||
Journal of Pediatric Perspectives | ||
مقاله 20، دوره 8، شماره 9 - شماره پیاپی 81، آذر 2020، صفحه 12075-12080 اصل مقاله (329.96 K) | ||
شناسه دیجیتال (DOI): 10.22038/ijp.2020.48616.3908 | ||
نویسندگان | ||
Seyed Hhosein Soleimanzadeh Mousavi* 1؛ Zeinab Tavakolikia2 | ||
1Resident of Pediatric, Department of Pediatrics, School of Medicine, Ali-Ibn-Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran. | ||
2Medical Practitioner, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. | ||
چکیده | ||
This review study aimed to examine the relationship between Coronavirus (COVID-19) and its uses in renin-angiotensin-aldosterone system (RAAS) to infect the patient using the related studies in this regard. Finally, the logical method of using the related medicine, and the benefits and harms of using these Medications will be indicated in the treatment of novel coronavirus. It is hoped that a short step will be taken in the attitude of scientists to plan further studies on the pediatric treatment of upgrading COVID-19. | ||
کلیدواژهها | ||
ACE2 enzyme؛ COVID-19؛ Pediatrics | ||
آمار تعداد مشاهده مقاله: 446 تعداد دریافت فایل اصل مقاله: 274 |